| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 51.144 | 53.398 | 81.406 | 111.785 |
| Total Income - EUR | - | - | - | - | - | - | 51.144 | 53.398 | 85.020 | 117.435 |
| Total Expenses - EUR | - | - | - | - | - | - | 7.831 | 10.493 | 43.223 | 70.338 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 43.313 | 42.905 | 41.797 | 47.097 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 42.812 | 42.381 | 41.174 | 43.810 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Eyeplastmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 63.807 | 281.213 |
| Current Assets | - | - | - | - | - | - | 43.486 | 43.149 | 29.539 | 19.926 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 3 | 11 |
| Receivables | - | - | - | - | - | - | 33.213 | 35.378 | 20.539 | 4.899 |
| Cash | - | - | - | - | - | - | 10.273 | 7.771 | 8.997 | 15.015 |
| Shareholders Funds | - | - | - | - | - | - | 42.852 | 42.430 | 41.222 | 43.858 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 657 | 762 | 16.226 | 228.381 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 36.591 | 30.740 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Eyeplastmed S.r.l.